Nemaline myopathy …

Developmental Malformations

Updated 07.20.2023
Released 12.16.1994
Expires For CME 07.20.2026

Nemaline myopathy

Authors: Yelena Wilson DO, Jennifer Baccon MD PhD MHCM

See Contributor Disclosures

Editor: Harvey B Sarnat MS MD FRCPC

Nemaline myopathy

In This Article

Quick Link

Introduction

Overview

Nemaline myopathy is probably the most common of the congenital myopathies and can present at any age. As the known causative gene mutations expand, the classification system continues to evolve.

Key points

	• Nemaline myopathy is the most common of the congenital myopathies.
	• Nemaline myopathy can present at any age with proximal muscle weakness, respiratory insufficiency, or bulbar dysfunction.
	• Childhood forms of nemaline myopathy are caused by mutations in numerous genes encoding muscle thin filaments.
	• Adult forms of nemaline myopathy can be more rapidly progressive and may be caused by immune dysregulation.

Historical note and terminology

Nemaline myopathy was first described in 1963 by investigators from the United States and Canada (18; 117). Nemaline myopathy is defined by a particular ultrastructural change on muscle biopsy: the finding of thread-shaped structures in muscle fibers, which are known as nemaline bodies, or rods (from the Greek nema, meaning thread).

Clinical manifestations

Presentation and course

Children with nemaline myopathy usually present with muscle weakness and hypotonia, which in most instances are apparent from the neonatal period or early infancy. The most severe (and probably most uncommon) form is that presenting as the fetal akinesia sequence (63).

The severe congenital form of nemaline myopathy manifests at delivery with severe hypotonia, minimal limb movement, and poor respiratory effort. Polyhydramnios and decreased fetal movements in pregnancy are common (101). Bulbar weakness causes poor feeding and recurrent aspiration. Early mortality is common and is usually due to respiratory insufficiency or aspiration pneumonia, although a minority of infants with severe generalized weakness survives long-term (71; 99; 07).

An intermediate form of nemaline myopathy was recognized in prior classification schemes; however, this category was clinically impractical and had no genotype-phenotype correlation, and thus has been combined into the typical form in the current classification system (65).

The mild or typical congenital form of nemaline myopathy is probably the most common form of this disease and usually presents in the neonatal period or first year of life with hypotonia, weakness, and feeding difficulties. Spontaneous antigravity movements are present and respiratory involvement is less prominent. Some weakness of the respiratory musculature is usual but may be subclinical or manifest only as frequent lower respiratory tract infections or silent nocturnal hypoventilation. A minority of cases presents after one year of age with delay of gross motor milestones, an abnormal waddling gait, or bulbar weakness manifesting as hypernasal speech or swallowing difficulties. Weakness is usually proximal at presentation, but late distal involvement in seen in approximately 20% of patients (101). Most patients survive into late childhood and adulthood, with static or slowly progressive weakness, and are able to lead an independent, active life.

Nemaline myopathy (Gowers sign)

To arise, this boy uses his arms for support, walking his hands up his legs. (Contributed by Dr. Susan Iannaccone.)

Childhood-onset nemaline myopathy presents with symmetrical distal lower limb weakness in early childhood, or less commonly with slowed limb movements (61; 103). Subsequent development of proximal weakness and wasting is associated in some cases, with progressive bulbar involvement and loss of ambulation by the age of 40 years.

More variability is seen in the late- or adult-onset form of nemaline myopathy, sometimes referred to as sporadic late-onset nemaline myopathy (SLONM), which presents between 20 and 50 years of age with rapidly progressive generalized limb girdle weakness and myalgia, usually without antecedent symptoms or family history (101). Cases can be associated with a monoclonal gammopathy, early HIV infection (65), or autoimmune disease (131). Atypical cases present with cardiomyopathy, or the “dropped head” syndrome. Respiratory involvement is uncommon, but occasional cases of nemaline myopathy present with adult-onset respiratory failure (57).

Nemaline myopathy affects the proximal limb muscles most severely, but all skeletal muscles, including the diaphragm, are involved. Muscle wasting is not invariable, but older children and adults are commonly slender. Proximal weakness is reflected in a wadding gait in ambulant patients. In adult-onset cases, initial distal weakness with foot drop and progressive gait abnormalities may be followed by later evolution of proximal involvement (61). In a minority of sporadic cases, weakness and joint contractures occur in a predominantly scapulohumeral distribution.

In the congenital forms of nemaline myopathy, the face is myopathic and expressionless, the mouth tent-shaped, and the palate high-arched.

Nemaline myopathy (facial weakness and habitus)

Patients often have a long, thin body habitus due to reduced muscle bulk. Facial weakness can be misinterpreted as flattening of affect. (Contributed by Dr. Susan Iannaccone.)

There may be retrognathia or relative micrognathia due to abnormal muscle stresses on the developing mandible. The extraocular muscles are usually spared. Generally, the finding of external ophthalmoplegia should raise suspicion of mitochondrial disease (31), but ophthalmoplegia has been reported in a form of severe nemaline myopathy associated with recessive RYR1 mutations (54). Dysarthria and dysphagia are common. Bulbar involvement may also be reflected in a hypernasal voice and wasting of the tongue. Weakness of the neck flexors causes difficulty in lifting the head against gravity when supine and weakness of the extensors presents as dropped head syndrome while standing. Peripherally, poor muscle bulk is associated with depressed or absent deep tendon reflexes. Gross motor milestones are delayed, but most patients are otherwise developmentally normal.

Respiratory involvement is virtually universal in congenital nemaline myopathy and is frequent in patients with onset in later life. In infancy, respiratory and limb weakness are generally similar in degree. Chest deformity may be present at birth or develop with increasing age. The variant of nemaline myopathy seen in the North American Amish community is known as “chicken breast disease” because of its frequent association with preterminal pectus carinatum (49). In older patients, subclinical restriction of respiratory capacity may develop as a result of respiratory muscle weakness, sleep apnea, poor clearance of secretions, and scoliosis. Nocturnal hypoxia places patients at risk of sudden respiratory failure with intercurrent infections (134; 106; 40).

Infants with congenital nemaline myopathy commonly have feeding difficulties and failure to thrive (101).

Nemaline myopathy in brothers

Two brothers, ages 4 and 10 years, with nemaline myopathy. Both boys had difficulty sucking and swallowing after birth. (Contributed by Dr. Susan Iannaccone.)

Myocardial involvement is unusual in congenital nemaline myopathy (101). A thorough review of the literature completed by Finsterer and Stollberger catalogs the cardiac manifestations in patients with nemaline myopathy, which include cardiomyopathy and cor pulmonale (28).

Arthrogryposis is occasionally reported in congenital nemaline myopathy, presumably as a result of decreased movement in utero (13; 101). In the Amish form of nemaline myopathy described by Johnston and colleagues, mild congenital contractures of the shoulders and hips progressed over the first few months of life in association with increasing hypotonia and weakness (49). Joint hypermobility may be seen in hypotonic infants and children with nemaline myopathy, but development of distal and large-joint contractures, and scoliosis, is common with increasing age. The rigid-spine syndrome is occasionally seen (134). Other uncommon manifestations include congenital fractures (14; 101), arachnodactyly, and clinodactyly.

The central nervous system and cognition are usually minimally or unaffected in nemaline myopathy (115; 134). Generalized myoclonus and minipolymyoclonus have rarely been described in congenital nemaline myopathy (17; 11), whereas the Amish variant of nemaline myopathy is marked by “abnormal vibratory fetal movements” and excessive neonatal jitteriness (49).

Prognosis and complications

Prognosis in nemaline myopathy is dependent on the severity of weakness of the respiratory, bulbar, and limb muscles. Early mortality is common, most often during the first year of life, and is almost invariably related to respiratory insufficiency. Arthrogryposis, neonatal respiratory failure, and failure to achieve early motor milestones are associated with a greater risk of early mortality (101). Surviving patients are at risk of recurrent pneumonia, aspiration, and chronic respiratory insufficiency (72; 41; 134). Prolonged respiratory insufficiency with chronic hypercarbia may lead to cor pulmonale. In such cases, nighttime noninvasive ventilation improves daytime oxygenation and exercise capacity, reduces cor pulmonale and may prolong survival. Other complications of nemaline myopathy include failure to thrive, bulbar weakness with dysarthria and speech delay, and orthopedic deformities including contractures and scoliosis (12).

Clinical vignette

JB was the first child of nonconsanguineous parents. The pregnancy was complicated by mild polyhydramnios. He was delivered at term by Cesarean section because of fetal distress, with a birth weight of 3200 gm. He required oxygen therapy for the first four days of life and had early difficulty with feeding due to a weak suck. Gastroesophageal reflux was identified on a barium swallow. Weight gain improved after the early introduction of solids.

From the first few days of life, his cry was weak and he drooled excessively. His eyes closed incompletely in sleep. He sat at 5 months, crawled at 1 year, and took his first steps at 20 months of age. During infancy, he had recurrent episodes of choking and numerous lower respiratory tract infections. His speech was markedly dysarthric.

When first seen by a neurologist at 20 months of age, he was thin, with poor muscle bulk, and a myopathic face. There was marked head lag and generalized hypotonia. Muscle power was decreased in all extremities and the tendon reflexes were hypoactive. Nerve conduction studies were normal. Needle electromyography revealed low-amplitude polyphasic motor unit action potentials. The serum creatine kinase was normal. On muscle biopsy, there was increased fiber size variation, with type 1 fiber predominance. The Gomori trichrome stain revealed nemaline bodies in most fibers. No intranuclear rods were seen on electron microscopy.

Echocardiography was unremarkable. A sleep study demonstrated occasional episodes of sleep apnea without significant desaturation.

With increasing age, a decrease in the frequency of his chest infections was accompanied by decreasing dysphagia and dysarthria. No progression of his weakness was apparent and his endurance appeared to improve. At 3 years of age he continued to make gains in all developmental spheres.

Biological basis

Etiology and pathogenesis

Nemaline myopathy is defined by the presence of nemaline rods in myofibers, when present in the appropriate clinical setting of muscle weakness.

Genetics. A growing number of genetic loci have now been identified for childhood-onset nemaline myopathy, all of which are associated with the thin filament of the sarcomere in skeletal muscle whether by encoding structures proteins or regulatory proteins. Mutations in NEB and ACTA1 are the most common, though many other affected genes have been described (in order of discovery) alpha-tropomyosin slow (gamma tropomyosin) (TPM3, chromosome 1q21-23) (62); nebulin (NEB, chromosome 2q21.2-22) (93); alpha-actin (ACTA1, chromosome 1q42.1) (90); troponin T1 (TNNT1, chromosome 19q13.4) (49); beta tropomyosin (TPM2, chromosome 9p13.2) (23); cofilin-2 (CFL2, chromosome 14q12) (01); KBTBD13 (chromosome 15q22) (103); ryanodine (RYR1) (54); KLHL40 (97); KLHL41 (37); and LMOD3 (leiomodin-3, chromosome 3p14.1) (144). The first six of these encode protein components of thin filaments of muscle fibers. KBTBD13 (BTB and Kelch domain containing 13 protein), KLHL40, and KLHL41 are members of the BTB/Kelch family, which is known to be involved in protein ubiquitination, although its exact function is unclear. RYR1 encodes the principal sarcoplasmic reticulum calcium-release channel, which plays a crucial role in excitation-contraction coupling. Leiomodin is a member of the tropomodulin protein family. MYPN mutations can cause nemaline myopathy and also cardiomyopathy (69). A case report suggests that RYR3 may be an additional causative gene (85). Myopathic changes with nemaline rods were seen in a patient with a filamin C mutation (26).

Mutations in several of these genes also cause other muscle disorders.

The mode of inheritance of nemaline myopathy is variable. Both autosomal dominant and autosomal recessive inheritance patterns exist, sometimes even for different mutations in the same gene.

Genotype-phenotype correlation in nemaline myopathy has been extensively studied. Most typical congenital cases are thought to be due to nebulin mutations, but nebulin nemaline myopathy can present at any point in life (138). The clinical phenotype of nebulin myopathy has been expanded with descriptions of a distal myopathy caused by recessive mutations in this gene, which can present as early as the first decade (137; 67). Actin mutations may be associated with a more severe clinical phenotype and with intranuclear rods, but marked phenotypic variability can be seen within kindreds (121; 43; 03; 36; 138). Actin mutations can also cause a milder dominant myopathy with cores, actin filament aggregate myopathy, and congenital fiber type disproportion (52; 60). There is a single report of actin aggregate myopathy in association with osteosclerosis and other morphologic abnormalities (05). Regardless of histopathologic phenotype, most individuals with actin mutations have severe muscle weakness, many dying in the first year of life (60). Cardiac function is generally normal in actin nemaline myopathy. This may relate to variable expression of cardiac and skeletal muscle isoforms of actin at various points in ontogenesis (42). Overall, the mildest phenotype seems to be the childhood-onset form of nemaline myopathy associated with dominant mutations of the alpha-tropomyosin gene, TPM3 (62; 94). Mutations in this gene have also been linked to congenital fiber type disproportion and cap myopathy (22; 66).

Rare, distinctive phenotypes associated with nemaline myopathy include the Amish form of the disease, which is associated with tremor, contractures, and progressive muscle weakness (49). Nemaline myopathy caused by dominant KBTBD13 mutations presents from early childhood with peculiarly slow voluntary movements and relative sparing of the facial and respiratory muscles (35; 103). Nemaline myopathy with cores may be associated with ryanodine receptor gene mutations (78; 107), or with mutations in KBTBD13 (103).

The cause of sporadic, late-onset nemaline myopathy is unknown, but the links with monoclonal gammopathy and with early HIV infection (during the phase of retained immunocompetence) have suggested a possible disorder of immune regulation. This postulate is given weight by reports of improved strength, respiratory capacity, and function after treatment of sporadic, adult-onset nemaline myopathy with melphalan and autologous stem-cell transplantation (09; 130; 77).

Sporadic late-onset nemaline myopathy seems to be related, in part, to aberrant immune activation (81). Proteomic profiling in cases of SLONM show upregulation of proteins related to the immune system including proteins involved in MHCI, MHCII, antigen processing, phagocytosis, and B and/or T cell function.

Pathophysiology. Alpha-actinin, an actin-binding protein, is the major component of the rods seen on histology, which constitute an extension of the sarcomeric Z-band (95; 48). Rods also contain nebulin, a thin filament protein (38), tropomyosin (122), and myotilin, a structural protein that cross-links to actin and has a role in formation and stabilization of Z-discs (109). Nebulin binds to actin, and the size of nebulin correlates with actin filament length, suggesting that nebulin may determine the length of the thin filaments during myofibrillogenesis (24). Nebulin may also act to increase activation of thin filaments and increase the force and efficiency of muscle contraction by altering crossbridge cycling kinetics (15; 34; 92). Studies on the nebulin knock-out mouse suggest that nebulin acts to regulate thin filament length and maintain Z-band width and myofibrillar connectivity, and that it may increase thin filament activation (15; 127).

Seven thin filament proteins are mutated in differing forms of nemaline myopathy. Most attach to the muscle Z-band, suggesting that rod formation may follow disruption of the point of attachment of muscle proteins to actin or alpha-actinin (46; 58). Mutations in ACTA1 may alter the conformation or stability of actin monomers or polymers, directly or through perturbation of actin-actin association or by disruption of binding with other proteins (45; 133; 76). Expression of actin mutants in myotubes results in apoptotic cell death (128). In a transgenic mouse model, disease severity seems to correlate with mutation load (96). Tropomyosin also has a role in stabilization of filamentous actin and may enhance actin polymerization. Skeletal muscle expresses 3 tropomyosin (Tm) isoforms from separate genes: alphaTm(fast) (alphaTm, TPM1), betaTm (TPM2), and alphaTm(slow) (gammaTm, TPM3). In an in-vitro model of alpha tropomyosin (TPM3)-related nemaline myopathy, mutant TPM3 was expressed and incorporated normally into striated muscle sarcomeres. Rod formation was seen only after active muscle contraction, suggesting that load-dependent processes are required for creation of nemaline bodies (73). In other studies, however, transfection of mutant TPM3 into myoblasts resulted in reduced incorporation into fibers and disruption of the filamentous actin network (44).

The level of betaTm, but not alphaTm(fast) protein, is reduced in human patients with mutations in alphaTm(slow) and in a transgenic mouse model of alphaTm(slow)(Met9Arg) nemaline myopathy, and the onset of alphaTm(slow)(Met9Arg) expression coincides with the decline of betaTm. Reduction of betaTm levels is independent of the degree of pathology (rods) within a muscle and is detected before the onset of muscle weakness. Alpha-tropomyosin(slow) dimers, composed of equal ratios of wild-type and M9R-alpha-tropomyosin(slow), are the dominant tropomyosin species in TPM3 nemaline myopathy. Myopathy-related slow-fiber predominance likely contributes to the severity of weakness in TPM3 nemaline myopathy because of increased proportions of fibers that express the mutant protein (44). The alphaTm(slow)(Met9Arg) mutation also acts to reduce the formation of the preferred alpha/beta heterodimer. This may alter sarcomeric thin filament dynamics, causing muscle weakness in nemaline myopathy (19). Developmental expression studies show that alpha-tropomyosin(slow) is not expressed at significant levels until after birth. This likely explains the later onset of TPM3 nemaline myopathy (44).

Nemaline myopathy related to troponin T1 deficiency is associated with complete loss of slow skeletal muscle troponin T, selective atrophy of type 1 fibers, and relative insensitivity to calcium (47). The nonsense mutation at codon Glu180 in this disorder causes production of a truncated troponin T protein, which has a decreased affinity for binding to tropomyosin because of loss of one of two tropomyosin binding sites. This truncated slow troponin T protein is rapidly degraded (142). The giant nebulin gene comprises 183 exons and contains four regions with alternatively spliced exons, giving rise to a number of different transcripts that vary among muscle types and among muscles of different developmental stages. Nebulin knockout mice have shortened thin filaments with abnormally wide Z-discs, resulting in decreased contractility (143). Extensive alternative splicing of NEB may explain why patients with nemaline myopathy and homozygous truncating mutations show expression of the carboxy-terminus of the nebulin protein, contrary to expectation, and may explain why severe phenotypes are rare among patients with two truncating mutations (24). Nebulin mutations are located through constitutively and alternatively expressed exons throughout the NEB gene, with no obvious mutational hotspots (68). Cofilin-2 is a small actin-binding protein predominantly expressed at sarcomeres. Its role in muscle development and function is unclear, but preservation of sarcomeric integrity may be contingent on developmentally specific expression of cofilin isoforms (01; 02).

Nemaline myopathy (photomicrograph) (1)

Transverse frozen sections of a vastus lateralis muscle biopsy of a child with nemaline myopathy. Hematoxylin-eosin stain fails to demonstrate the rod-shaped structures or any specific myopathic features (left). Modified Gomori tr...
Nemaline myopathy (photomicrograph) (2)

Longitudinal paraffin-embedded sections of vastus lateralis muscle of a child with nemaline myopathy. Hematoxylin-eosin (not shown) and Gomori trichrome (not shown) did not demonstrate nemaline rods, but they are clearly seen on f...
Nemaline myopathy (electron micrograph)

A longitudinal section of normal muscle fiber, with intact sarcomeric structure, is flanked by one showing myofibrillar disruption and aggregates of material. These aggregates have the same electron density and periodicity as Z-ba...

Nemaline myopathy with cores is seen with ryanodine receptor gene mutations (78; 107) and with the form of nemaline myopathy associated with mutations in KBTBD13 (103).

Other proteins of the sarcolemmal cytoskeleton have also been studied in nemaline myopathy. Rods do not contain titin (112) or nebulin. Desmin is increased in fibers containing rods (126; 105) and accumulates at the periphery of rods in some patients (112). Sarcolemmal dystrophin is normal in nemaline myopathy, but spectrin studies may be abnormal in severe cases (111).

Desmin immunoreactivity (photomicrograph)

Desmin immunoreactivity is seen focally in the regions of rod accumulation within myofibrils and also in perinuclear zones. It may be demonstrated in either frozen or paraffin sections. (x400) (Contributed by Dr. Susan Iannaccone....

Increased expression of cardiac ankyrin repeat protein, a nuclear protein that may act as a negative regulator of cardiac-specific gene protein, has been identified in nemaline myopathy, a finding that is of unclear significance but may reflect persistent expression or upregulation of fetal muscle proteins (100). In actin nemaline myopathy, upregulation of a fetal cardiac actin isoform may ameliorate muscle weakness (89). Developmental regulation of muscle protein expression may affect presentation of a number of forms of nemaline myopathy (47; 89; 02).

On immunocytochemical examination, nemaline bodies consist primarily of alpha-actinin (48) and have structural similarity to the Z-lines of muscle sarcomeres. Antibodies to alpha-actinin 2 (ACTN2) and alpha-actinin 3 (ACTN3) stain Z-lines and rods in skeletal muscle. Rod composition is usually fiber-type dependent, with alpha-actinin 2 being present in rods in all fibers, whereas alpha-actinin 3 is present only in rods in type 2 muscle fibers (87), but this is not absolute. In some cases, alpha-actinin isoforms within rods do not conform to fiber-type specific proteins expressed in other parts of the myofibril, suggesting the possibility of fiber-type conversion. This is supported by the finding, in some muscle fibers, of coexpression of fast and slow myosin isoforms (111; 100). Immunocytochemical studies also demonstrate myotilin immunoreactivity in rods of slow and fast twitch fibers (109).

Gene expression studies in nemaline myopathy have identified downregulation of transcripts of enzymes of glucose and glycogen metabolism, altered transcription of genes involved in calcium homeostasis, and increased expression of structural proteins involved in muscle fibrosis (104). The significance of these changes, which occur downstream from the primary molecular abnormalities of nemaline myopathy, is unclear at this time.

Respiratory chain enzyme analysis has shown complex 1 deficiency in cases of nemaline myopathy related both to nebulin and actin mutations (64; 136).

The cellular mechanism underlying loss of muscle strength in nemaline myopathy is poorly understood. Weakness may be due to myocyte loss, abnormal fiber-typing, or myocyte immaturity. Sarcomeric disorganization, with an excess of thin filaments, is common in congenital nemaline myopathy (32; 43; 100) and may become more marked on serial biopsies (139; 100). Sarcomeric disarray may result from altered interaction of mutated thin filaments with Z-line proteins such as alpha-actinin or tropomodulin, resulting in formation of nemaline bodies and loss of contractility (79; 45; 01; 44). Alternatively, weakness may result from desensitization of calcium-activated muscle contraction, or temporal alterations in the contraction-relaxation cycle of skeletal muscles, resulting in altered regulation of force production (73; 74). In actin nemaline myopathy, weakness may be partially compensated by upregulation of alpha-cardiac actin, the skeletal muscle fetal actin isoform (89).

Type 1 fiber predominance in nemaline myopathy may be due to abnormalities of fiber type maturation, active conversion of type 2 to type 1 fibers, or a combination of these processes (132; 116). An increase in slow oxidative fibers may occur as a means of preserving muscle strength, oxidative metabolism being more energy efficient (123). In a mouse model of alpha-tropomyosin deficiency, exercise does not appear to worsen the pathologic phenotype of nemaline myopathy, but it does alter fiber-type conversion in a muscle- and fiber-type specific manner (83). A minority of patients with nemaline myopathy has no alteration of fiber typing or fiber size variation on biopsy (139). This pathological heterogeneity may reflect variable pathogenesis of rod formation in different genetic subtypes of nemaline myopathy. Rod composition and actin dynamics differ in genetic and secondary forms of nemaline myopathy, suggesting that rod formation represents a common morphological endpoint of a variety of different pathological processes (129).

Diagnostic workup

Muscle enzymes are usually normal in nemaline myopathy but may be mildly elevated. Electromyography may show normal motor unit potentials or small, short-duration action potentials consistent with a myopathic process (134; 101). Nerve conduction studies are usually normal.

Diagnosis depends on the finding of nemaline rods on muscle biopsy. Nemaline bodies are best seen with the modified Gomori trichrome stain of fresh frozen sections; they look dark purple and granular under the light microscope.

Nemaline myopathy (photomicrograph) (3)

A muscle biopsy showing the typical appearance of rod bodies on light microscopy (modified Gomori trichrome stain; x400). (Contributed by Dr. Susan Iannaccone.)

Rods are most frequently located in the subsarcolemmal region. Rod number varies widely between patients, between different muscles in a single patient, and even between different parts of a muscle (84; 114). The number and distribution of nemaline bodies do not tend to correlate with age of presentation or clinical severity of nemaline myopathy (116; 100). In most patients, numerous rods are seen in most or all extrafusal muscle fibers (114), but in some cases they are apparent only in type 1 fibers. Intrafusal fibers do not contain rods (117). On electron microscopy, rods are often associated with marked sarcomeric disorganization and loss of normal sarcomeric registration (43; 100). Not infrequently, however, areas of complete sarcomeric disarray will abut relatively normal sarcomeres, a phenomenon that remains poorly understood. Numerous nemaline bodies, glycogen accumulation, and marked sarcomeric disruption are more common in nemaline myopathy associated with mutations in skeletal alpha-actin, whereas nemaline myopathy due to mutations in alpha-tropomyosin may be characterized by preferential rod formation in, and atrophy of, type 1 fibers (100).

In most patients nemaline bodies are confined to the sarcoplasm. Rods are occasionally also seen in sarcomeric nuclei. The presence of intranuclear rods appears to correlate with poor prognosis: they have been seen both in cases of severe neonatal nemaline myopathy (98; 08; 33) and in a minority of progressive adult cases (25; 91). Intranuclear rods may be more common in actin nemaline myopathy (138; 56).

Predominance of type 1 fibers is common in nemaline myopathy, often with a decrease in type 1 fiber diameter (30; 75). Internal nuclei are common and fiber splitting is occasionally seen. These changes tend to progress with age. Inflammatory changes are not characteristic of nemaline myopathy, but occasional necrotic or regenerating fibers may be seen in patients with progressive adult-onset disease and reactivity for MHCI by immunohistochemistry can be seen in fibers with rods as well as adjacent nonatrophic fibers (81). Acid phosphatase activity is also increased in patients with rapid progression (86; 11). Progressive muscle fibrosis may be seen on serial muscle biopsies (139; 100).

Nemaline myopathy with fiber-type disproportion (photomicrograph)

Most cases of nemaline myopathy are accompanied by muscle fiber-type disproportion, in which histochemical type I myofibers (light) are more numerous and uniformly smaller than those of type II. Some cases show apparently complete...

Nemaline bodies are not pathognomonic of nemaline myopathy. Nemaline bodies have been reported in normal human extraocular muscle (80; 70), with aging, and after tenotomy and radiotherapy. Rod formation can represent a nonspecific response to muscle damage. Nemaline bodies have been reported in a number of neuromuscular and unrelated conditions, including amyotrophic lateral sclerosis, polymyositis, oculopharyngeal and limb-girdle muscular dystrophy, chorea-acanthocytosis, neurosarcoidosis, and diploid/triploid mosaicism (118; 39; 64; 125; 113). Nemaline bodies were identified in the muscle of a child with Timothy syndrome, a multisystem disorder with congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities, and autism. Timothy syndrome is due to a mutation in a cardiac L-type calcium channel (120).

Ultrastructural changes suggestive of other congenital myopathies, such as cores, minicores, caps, or zebra bodies are commonly seen in patients with nemaline myopathy (53; 110; 20; 124; 01; 89). Cores are characteristically seen in the nemaline myopathies caused by ryanodine receptor gene mutations (78; 107) and KBTBD13 mutations (103). Nemaline myopathy has also been associated with congenital fiber-type disproportion (30; 75) and cap disease (124). Mutations in both actin and tropomyosin have been identified in patients with fiber-type disproportion without rod formation, expanding the clinical spectrum of myopathies associated with the genes (59; 16).

The diagnosis of nemaline myopathy is, therefore, not justified in the absence of a typical clinical picture. It may be that, in the congenital myopathies, common secondary changes in muscle develop in response to varied primary insults.

Other investigations to consider in patients with nemaline myopathy include electrocardiography and echocardiography in order to exclude the possibility of an associated cardiomyopathy. Pulmonary function tests identify subclinical respiratory disease and those at risk of acute decompensation with anesthesia or pneumonia. Sleep studies identify patients with nocturnal carbon dioxide retention and hypoventilation. Chronic pulmonary insufficiency may cause development of cor pulmonale (41). Serial testing of cardiac and pulmonary function is indicated, as there may be deterioration with increasing age.

Muscle MRI may have a place in diagnosis of nemaline myopathy and may help direct genetic testing. A report of muscle MRI in patients with actin and nebulin nemaline myopathy identified characteristic patterns of abnormality in both conditions. Patients with actin mutations had diffuse involvement of thigh and leg muscles, with relative sparing of the gastrocnemii, whereas nebulin nemaline myopathy was associated with selective involvement of the tibialis anterior and soleus, the thigh muscles showing changes only in nonambulant patients (51). Whether these patterns prove predictive in patients with an unknown genotype or just reflect disease severity remains to be seen.

Management

Supportive therapy. No therapies can at this time alter the essential nature or clinical progression of the congenital myopathies. Treatment is, therefore, aimed at early diagnosis, maintenance of function, and treatment of complications. Standards of care for congenital myopathy are now available and should guide clinical management (141). Respiratory disease is the major cause of morbidity and mortality in nemaline myopathy. In neonatal cases, supportive therapy can be offered in the form of mechanical ventilation, but patients requiring respiratory support at this age have a generally poor prognosis (101). Long-term assisted ventilation has been undertaken in a small number of older patients with nemaline myopathy (115). Noninvasive nocturnal ventilation is an important therapeutic option in older patients with chronic respiratory failure and cor pulmonale. The onset of respiratory failure may be insidious (119), with rapid decompensation in respiratory and cardiac function with intercurrent respiratory tract infections. In some cases, brief periods of assisted ventilation during acute respiratory illnesses may prolong survival (106), although recovery to a point where ventilatory assistance can be withdrawn can be difficult to predict. Pulmonary infections should be treated promptly with chest physiotherapy and antibiotics. Immunizations, including those against pneumococcus and influenza, may help to minimize the incidence of pneumonia.

Bulbar dysfunction is common in nemaline myopathy and often causes aspiration of oral secretions. Evaluation of adequacy of the swallow should be a part of the initial assessment and should be reviewed if symptoms referable to aspiration are identified. Nutritional support is especially important in those with impaired bulbar function. Failure to thrive may be related both to poor intake and to the increased metabolic demands imposed by recurrent aspiration pneumonitis. Malnutrition has been implicated as a cause of significant morbidity in younger patients with nemaline myopathy (88). Nasogastric tube feedings or placement of a gastrostomy may be necessary to maintain nutrition in infants. Accelerated weight gain and improvement of respiratory function may follow gastrostomy with or without fundoplication (10).

Symptomatic cardiac involvement is uncommon in nemaline myopathy, but echocardiography is useful in identification of incipient cor pulmonale and prompt introduction of assisted ventilation. The QT interval should be assessed in children with nemaline myopathy and dysmorphic or autistic features in order to exclude the Timothy syndrome (120).

Physical therapy for nemaline myopathy should include daily passive range of motion exercises to prevent contracture formation. Exercise does not appear to worsen the pathologic phenotype of nemaline myopathy, but changes in muscle morphology after exercise are influenced by the causative mutation (83). Patients should be mobilized as soon as possible after surgery, as prolonged immobility may significantly exacerbate muscle weakness (101). One published murine study suggests that immobility may be associated with the reversible formation of additional nemaline bodies in muscle (50). Orthopedic intervention may be required in patients with congenital and acquired contractures, pathological fractures secondary to disuse osteopenia, and scoliosis. The timing of procedures is crucial in determining their efficacy and safety. Prior to any anesthesia or sedation, all patients should undergo a thorough preoperative assessment with consideration of potential anesthetic difficulties and respiratory reserve.

Drug therapy. The only specific treatment for the genetic forms of nemaline myopathy identified to date is L-tyrosine, a precursor of the neurotransmitters dopamine, norepinephrine, and epinephrine. L-tyrosine has been shown in rats to increase catecholamine production and release, improve reaction and attention time, and improve tolerance of physical stress, and, in some children with nemaline myopathy, appears to improves bulbar function and exercise tolerance when given orally at a dose of 250 to 3000 mg/day (102).

There is an array of early clinical and preclinical therapies being evaluated (11 such therapies are summarized in a study by Fisher) (29); however, all treatments at this time are supportive.

Sporadic late-onset nemaline myopathy first-line treatment consists of IVIg (82). Daratumumab (108), rituximab, methotrexate, and other agents generally considered to be cancer therapies have been reportedly used with varying levels of success, though the role of chemotherapy in this condition is currently controversial. Autologous stem cell transplant with or without chemotherapy in the setting of monoclonal gammopathy has also been recommended by several authors.

Media

References

01: Agrawal PB, Greenleaf RS, Tomczak KK, et al. Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2. Am J Hum Genet 2007;80(1):162-7. PMID 17160903
02: Agrawal PB, Joshi M, Savic T, Chen Z, Beggs AH. Normal myofibrillar development followed by progressive sarcomeric disruption with actin accumulations in a mouse Cfl2 knockout demonstrates requirement of cofilin-2 for muscle maintenance. Hum Molec Genet 2012;21(10):2341-56. PMID 22343409
03: Agrawal PB, Strickland CD, Midgett C, et al. Heterogeneity of nemaline myopathy cases with skeletal muscle alpha-actin gene mutations. Ann Neurol 2004;56(1):86-96. PMID 15236405
04: Anderson SL, Ekstein J, Donnelly MC, et al. Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene. Hum Genet 2004;115(3):185-90. PMID 15221447
05: Arai A, Mitsuhashi S, Saito Y, et al. Nemaline (actin) myopathy with myofibrillar dysgenesis and abnormal ossification. Neuromuscul Disord 2009;19(7):485-8. PMID 19553121
06: Asai T, Fujise K, Uchida M. Anaesthesia for cardiac surgery in children with nemaline myopathy. Anaesthesia 1992;47:405-8. PMID 1599065
07: Banwell BL, Singh NC, Ramsay DA. Prolonged survival in neonatal nemaline myopathy. Pediatr Neurol 1994;10(4):335-7. PMID 8068164
08: Barohn RJ, Jackson CE, Kagan-Hallet KS. Neonatal nemaline myopathy with abundant intranuclear rods. Neuromuscul Disord 1994;4:513-20. PMID 7881297
09: Benveniste O, Laforet P, Dubourg O, et al. Stem cell transplantation in a patient with late-onset nemaline myopathy and gammopathy. Neurology 2008;71(7):531-2. PMID 18565830
10: Berezin S, Newman LJ, Schwarz SM, Spiro AJ. Gastroesophageal reflux associated with nemaline myopathy of infancy. Pediatrics 1988;81(1):111-5. PMID 3336576
11: Bergmann M, Kamarampaka M, Kuchelmeister K, Klein H, Koch H. Nemaline myopathy: two autopsy reports. Childs Nerv Syst 1995;11(10):610-5. PMID 8556730
12: Bodensteiner JB. Congenital myopathies. Muscle Nerve 1994;17:131-44. PMID 8114781
13: Bucher HU, Boltshauser E, Briner J. Neonatal nemaline myopathy presenting with multiple joint contractures. Eur J Pediatr 1985;144:288-90. PMID 2414108
14: Buonocore G, Balestri P, Toti P, Bagnoli F. A new case of severe congenital nemaline myopathy. Acta Paediatr 1993;82(12):1082-4. PMID 8155933
15: Chandra M, Mamidi R, Ford S, et al. Nebulin alters cross-bridge cycling kinetics and increases thin filament activation: a novel mechanism for increasing tension and reducing tension cost. J Biol Chem 2009;284(45):30889-96. PMID 19736309
16: Clarke NF, Kolski H, Dye DE, et al. Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol 2008;63(3):329-37. PMID 18300303
17: Colamaria V, Zanetti R, Simeone M, Tomelleri G, Orrico D, Dordi B. Minipolymyoclonus in congenital nemaline myopathy: a nonspecific clinical marker of neurogenic dysfunction. Brain Dev 1991;13:358-62. PMID 1785661
18: Conen PE, Murphy EG, Donohue WL. Light and electron microscopic studies of "myogranules" in a child with hypotonia and muscle weakness. Can Med Assoc J 1963;89:983-6. PMID 14076166
19: Corbett MA, Akkari AP, Domazetovska A, et al. An alphaTropomyosin mutation alters dimer preference in nemaline myopathy. Ann Neurol 2005;57:42-9. PMID 15562513
20: Cuisset JM, Maurage CA, Pellissier JF, et al. 'Cap myopathy': case report of a family. Neuromuscul Disord 2006;16(4):277-81. PMID 16531045
21: Cunliffe M, Burrows FA. Anaesthetic implications of nemaline rod myopathy. Can Anaesth Soc J 1985;32:543-7. PMID 4041956
22: De Paula AM, Franques J, Fernandez C, et al. A TPM3 mutation causing cap myopathy. Neuromuscul Disord 2009;19(10):685-8. PMID 19553118
23: Donner K, Ollikainen M, Ridanpaa M, et al. Mutations in the beta-tropomyosin (TPM2) gene--a rare cause of nemaline myopathy. Neuromuscul Disord 2000;12(2):151-8. PMID 11738357
24: Donner K, Sandbacka M, Lehtokari VL, Wallgren-Pettersson C, Pelin K. Complete genomic structure of the human nebulin gene and identification of alternatively spliced transcripts. Eur J Hum Genet 2004;12(9):744-51. PMID 15266303
25: Engel WK, Oberc MA. Abundant nuclear rods in adult onset rod disease. J Neuropathol Exp Neurol 1975;34(2):119-32. PMID 47386
26: Evangelista T, Lornage X, Carlier PG, et al. A heterozygous mutation in the filamin C gene causes an unusual nemaline myopathy with ring fibers. J Neuropathol Exp Neurol 2020;79(8):908-14. PMID 32607581
27: Felber AR, Jelen-Esselborn S. Anesthesia in a patient with congenital nemaline type myopathy. Anaesthesist 1990;39(7):378-81. PMID 2386307
28: Finsterer J, Stollberger C. Review of cardiac disease in nemaline myopathy. Pediatr Neurol 2015;53(6):473-7. PMID 26507755
29: Fisher G, Mackels L, Markati T, et al. Early clinical and pre-clinical therapy development in nemaline myopathy. Expert Opin Ther Targets 2022;26(10):853-67. PMID 36524401
30: Fukuhara N, Yuasa T, Tsubaki T, Kushiro S, Takasawa N. Nemaline myopathy: histological, histochemical and ultrastructural studies. Acta Neuropathol 1978;42:33-41. PMID 654876
31: Fukunaga H, Osame M, Arimura Y, Igata A. A case of nemaline myopathy with ophthalmoplegia and mitochondrial abnormalities. Rinsho Shinkeigaku 1978;18(1):35-43. PMID 630764
32: Goebel HH, Piirsoo A, Warlo I, Schofer O, Kehr S, Gaude M. Infantile intranuclear rod myopathy. J Child Neurol 1997;12:22-30. PMID 9010792
33: Goebel HH, Warlo I. Nemaline myopathy with intranuclear rods–intranuclear rod myopathy. Neuromuscul Disord 1997;7(1):13-9. PMID 9132135
34: Gokhin DS, Bang ML, Zhang J, Chen J, Lieber RL. Reduced thin filament length in nebulin-knockout skeletal muscle alters isometric contractile properties. Am J Physiol Cell Physiol 2009;296(5):C1123-32. PMID 19295172
35: Gommans IM, Davis M, Saar K, et al. A new locus on chromosome 15q for a dominantly inherited nemaline myopathy clinically characterized by muscle slowness. J Musc Res Cell Motil 2002;23:36. PMID 12805120
36: Graziano C, Bertini E, Minetti C, Porfirio B. Alpha-actin gene mutations and polymorphisms in Italian patients with nemaline myopathy. Int J Mol Med 2004;13(6):805-9. PMID 15138616
37: Gupta VA, Ravenscroft G, Shaheen R, et al. Identification of KLHL41 mutations implicates BTB-Kelch-mediated ubiquitination as an alternate pathway to myofibrillar disruption in nemaline myopathy. Am J Hum Genet 2013;93(6):1108-17. PMID 24268659
38: Gurgel-Giannetti J, Reed U, Bang ML, et al. Nebulin expression in patients with nemaline myopathy. Neuromuscul Disord 2001;11(2):154-62. PMID 11257471
39: Hauser MA, Horrigan SK, Salmikangas P, et al. Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet 2000;9(14):2141-7. PMID 10958653
40: Howard RS, Wiles CM, Hirsch NP, Spencer GT. Respiratory involvement in primary muscle disorders: assessment and management. Q J Med 1993;86(3):175-89. PMID 8483991
41: Iannaccone ST, Guilfoile T. Long-term mechanical ventilation in infants with neuromuscular disease. J Child Neurol 1988;3:30-2. PMID 3125240
42: Ilkovski B, Clement S, Sewry C, North KN, Cooper ST. Defining alpha-skeletal and alpha-cardiac actin expression in human heart and skeletal muscle explains the absence of cardiac involvement in ACTA1 nemaline myopathy. Neuromuscul Disord 2005;15(12):829-35. PMID 16288873
43: Ilkovski B, Cooper ST, Nowak K, et al. Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin gene. Am J Hum Genet 2001;68:1333-43. PMID 11333380
44: Ilkovski B, Mokbel N, Lewis RA, et al. Disease severity and thin filament regulation in M9R TPM3 nemaline myopathy. J Neuropathol Exp Neurol 2008;67(9):867-77. PMID 18716557
45: Ilkovski B, Nowak KJ, Domazetovska A, et al. Evidence for a dominant-negative effect in ACTA1 nemaline myopathy caused by abnormal folding, aggregation and altered polymerization of mutant actin isoforms. Hum Mol Genet 2004;13(16):1727-43. PMID 15198992
46: Jennekens FG, Roord JJ, Veldman H, Willemse J, Jockusch BM. Congenital nemaline myopathy. I. Defective organization of alpha-actinin is restricted to muscle. Muscle Nerve 1983;6:61-8. PMID 6302502
47: Jin JP, Brotto MA, Hossain MM, et al. Truncation by Glu180 nonsense mutation results in complete loss of slow skeletal muscle troponin T in a lethal nemaline myopathy. J Biol Chem 2003;278(28):26159-65. PMID 12732643
48: Jockusch BM, Veldman H, Griffiths GW, van Oost BA, Jennekens FG. Immunofluorescence microscopy of a myopathy. Alpha-actinin is a major constituent of nemaline rods. Exp Cell Res 1980;127:409-20. PMID 6991264
49: Johnston JJ, Kelley RI, Crawford TO, et al. A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. Am J Hum Genet 2000;67:814-21. PMID 10952871
50: Joya JE, Kee AJ, Nair-Shalliker V, et al. Muscle weakness in a mouse model of nemaline myopathy can be reversed with exercise and reveals a novel myofiber repair mechanism. Hum Mol Genet 2004;13(21):2633-45. PMID 15367485
51: Jungbluth H, Sewry CA, Counsell S, et al. Magnetic resonance imaging of muscle in nemaline myopathy. Neuromuscul Disord 2004;14(12):779-84. PMID 15564032
52: Kaindl AM, Ruschendorf F, Krause S, et al. Missense mutations of ACTA1 cause dominant congenital myopathy with cores. J Med Genet 2004;41(11):842-8. PMID 15520409
53: Karpati G, Carpenter S, Eisen AA. Experimental core-like lesions and nemaline rods. A correlative morphological and physiological study. Arch Neurol 1972;27:237-51. PMID 4115162
54: Kondo E, Nishimura T, Kosho T, et al. Recessive RYR1 mutations in a patient with severe congenital nemaline myopathy with ophthalmoplegia identified through massively parallel sequencing. Am J Med Genet Part A 2012;158A(4):772-8. PMID 22407809
55: Konno H, Iwasaki Y, Yamamoto T, Inosaka T. Nemaline bodies in spinal progressive muscular atrophy. An autopsy case. Acta Neuropathol 1987;74:84-8. PMID 2821729
56: Koy A, Ilkovski B, Laing N, et al. Nemaline myopathy with exclusively intranuclear rods and a novel mutation in ACTA1 (Q139H). Neuropediatrics 2007;38(6):282-6. PMID 18461503
57: Kudou M, Kobayashi Y, Yamashita K, Kita H, Yasuba H, Hamada K. Two cases of nemaline myopathy diagnosed after episodes of respiratory failure [in Japanese]. Nihon Kokyuki Gakkai Zasshi 2006;44(6):474-8. PMID 16841721
58: Labeit S, Kolmerer B. The complete primary structure of human nebulin and its correlation to muscle structure. J Mol Biol 1995;248(2):308-15. PMID 7739042
59: Laing NG, Clarke NF, Dye DE, et al. Actin mutations are one cause of congenital fibre type disproportion. Ann Neurol 2004;56(5):689-94. PMID 15468086
60: Laing NG, Dye DE, Wallgren-Pettersson C, et al. Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1). Hum Mutat 2009;30(9):1267-77. PMID 19562689
61: Laing NG, Majda BT, Akkari PA, et al. Assignment of a gene (NEM1) for autosomal dominant nemaline myopathy to chromosome 1. Am J Hum Genet 1992;50(3):576-83. PMID 1347195
62: Laing NG, Wilton SD, Akkari PA, et al. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet 1995;10(2):249. PMID 7663526
63: Lammens M, Moerman P, Fryns JP, et al. Fetal akinesia sequence caused by nemaline myopathy. Neuropediatrics 1997;28(2):116-9. PMID 9208412
64: Lamont PJ, Thorburn DR, Fabian V, et al. Nemaline rods and complex I deficiency in three infants with hypotonia, motor delay and failure to thrive. Neuropediatrics 2004;35(5):302-6. PMID 15534765
65: Laitila J, Wallgren-Pettersson C. Recent advances in nemaline myopathy. Neuromuscul Disord 2021;31(10):955-67. PMID 34561123
66: Lawlor MW, Dechene ET, Roumm E, Geggel AS, Moghadaszadeh B, Beggs AH. Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat 2010;31(2):176-83. PMID 19953533
67: Lehtokari VL, Pelin K, Herczegfalvi A, et al. Nemaline myopathy caused by mutations in the nebulin gene may present as a distal myopathy. Neuromuscul Disord 2011;21(8):556-62. PMID 21724397
68: Lehtokari VL, Pelin K, Sandbacka M, et al. Identification of 45 novel mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Hum Mutat 2006;27(9):946-56. PMID 16917880
69: Lornage X, Malfatti E, Chéraud C, et al. Recessive MYPN mutations cause cap myopathy with occasional nemaline rods. Ann Neurol 2017;81(3):467-73. PMID 28220527
70: Martinez AJ, Hay S, McNeer KW. Extraocular muscles: light microscopy and ultrastructural features. Acta Neuropathol 1976;34:237-53. PMID 178143
71: Martinez BA, Lake BD. Childhood nemaline myopathy: a review of clinical presentation in relation to prognosis. Dev Med Child Neurol 1987;29(6):815-20. PMID 2826280
72: Matsuo T, Tashiro T, Ikeda T, Tsujihata M, Shimomura C. Fatal neonatal nemaline myopathy. Acta Pathol Jpn 1982;32(5):907-16. PMID 6182741
73: Michele DE, Albayya FP, Metzger JM. A nemaline myopathy mutation in alpha-tropomyosin causes defective regulation of striated muscle force production. J Clin Invest 1999;104(11):1575-81. PMID 10587521
74: Michele DE, Coutu P, Metzger JM. Divergent abnormal muscle relaxation by hypertrophic cardiomyopathy and nemaline myopathy mutant tropomyosins. Physiol Genomics 2002;9(2):103-11. PMID 12006676
75: Miike T, Ohtani Y, Tamari H, Ishitsu T, Une Y. Muscle fiber type transformation in nemaline myopathy and congenital fiber type disproportion. Brain Dev 1986;8:526-32. PMID 3799921
76: Miller BM, Trybus KM. Functional effects of nemaline myopathy mutations on human skeletal alpha-actin. J Biol Chem 2008;283(28):19379-88. PMID 18477565
77: Milone M, Katz A, Amato AA, et al. Sporadic late onset nemaline myopathy responsive to IVIg and immunotherapy. Muscle Nerve 2010;41(2):272-6. PMID 19852026
78: Monnier N, Romero NB, Lerale J, et al. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. Hum Mol Genet 2000;9:2599-608. PMID 11063719
79: Mudry RE, Perry CN, Richards M, Fowler VM, Gregorio CC. The interaction of tropomodulin with tropomyosin stabilizes thin filaments in cardiac myocytes. J Cell Biol 2003;162:1057-68. PMID 12975349
80: Mukuno K. Electron microscopic studies on the human extraocular muscles under pathologic conditions. I. Pathologic findings, especially "rod formation" occurring in normal extraocular muscles and in the extraocular muscle of a patient with polymyositis. Nippon Ganka Gakkai Zasshi 1968;72(9):1678-90. PMID 5751572
81: Naddaf E, Dasari S, Selcen D, et al. Proteomic profiling of sporadic late-onset nemaline myopathy. Ann Clin Transl Neurol 2022;9(3):391-402. PMID 35187860
82: Naddaf E, Milone M, Kansagra A, Buadi F, Kourelis T. Sporadic late-onset nemaline myopathy: clinical spectrum, survival, and treatment outcomes. Neurology 2019;93(3):e298-e305. PMID 31167932
83: Nair-Shalliker V, Kee AJ, Joya JE, et al. Myofiber adaptational response to exercise in a mouse model of nemaline myopathy. Muscle Nerve 2004;30(4):470-80. PMID 15372535
84: Nienhuis AW, Coleman RF, Brown WJ, Munsat TL, Pearson CM. Nemaline myopathy. A histopathologic and histochemical study. Am J Clin Pathol 1967;48(1):1-13. PMID 4165764
85: Nilipour Y, Nafissi S, Tjust AE. Ryanodine receptor type 3 (RYR3) as a novel gene associated with a myopathy with nemaline bodies. Eur J Neurol 2018;25(6):841-7. PMID 29498452
86: Nonaka I, Ishiura S, Arahata K, Ishibashi-Ueda H, Maruyama T, Ii K. Progression in nemaline myopathy. Acta Neuropathol 1989;78:484-91. PMID 2683560
87: North KN, Beggs AH. Deficiency of a skeletal muscle isoform of alpha-actinin (alpha-actinin-3) in merosin-positive congenital muscular dystrophy. Neuromuscul Disord 1996;6(4):229-35. PMID 8887951
88: Norton P, Ellison P, Sulaiman AR, Harb J. Nemaline myopathy in the neonate. Neurology 1983;33(3):351-6. PMID 6681881
89: Nowak KJ, Sewry CA, Navarro C, et al. Nemaline myopathy caused by absence of alpha-skeletal muscle actin. Ann Neurol 2007;61(2):175-84. PMID 17187373
90: Nowak KJ, Wattanasirichaigoon D, Goebel HH, et al. Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet 1999;23:208-12. PMID 10508519
91: Otsuji Y, Osame M, Tei C, et al. Cardiac involvement in congenital myopathy. Int J Cardiol 1985;9:311-22. PMID 4055149
92: Ottenheijm CA, Hooijman P, DeChene ET, Stienen GJ, Beggs AH, Granzier H. Altered myofilament function depresses force generation in patients with nebulin-based nemaline myopathy (NEM2). J Struct Biol 2010;170(2):334-43. PMID 19944167
93: Pelin K, Hilpela P, Donner K, et al. Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci USA 1999;96:2305-10. PMID 10051637
94: Penisson-Besnier I, Monnier N, Toutain A, Dubas F, Laing N. A second pedigree with autosomal dominant nemaline myopathy caused by TPM3 mutation: a clinical and pathological study. Neuromuscul Disord 2007;17(4):330-7. PMID 17376686
95: Price HM, Gordon GB, Pearson CM, Munsat TL, Blumberg JM. New evidence for excessive accumulation of Z-band material in nemaline myopathy. Proc Natl Acad Sci U S A 1965;54:1398-406. PMID 5218258
96: Ravenscroft G, Jackaman C, Bringans S, et al. Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies. Brain 2011;134(Pt 4):1101-15. PMID 21303860
97: Ravenscroft G, Miyatake S, Lehtokari VL, et al. Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy. Am J Hum Genet 2013;93(1):6-18. PMID 23746549
98: Rifai Z, Kazee AM, Kamp C, Griggs RC. Intranuclear rods in severe congenital nemaline myopathy. Neurology 1993;43(11):2372-7. PMID 8232959
99: Roig M, Hernandez MA, Salcedo S. Survival from symptomatic nemaline myopathy in the newborn period. Pediatr Neurosci 1987;13(2):95-7. PMID 3438219
100: Ryan MM, Ilkovski B, Strickland CD, et al. Clinical course correlates poorly with muscle pathology in nemaline myopathy. Neurology 2003;60:665-73. PMID 12601110
101: Ryan MM, Schnell C, Strickland CD, et al. Nemaline myopathy: a clinical study of 143 cases. Ann Neurol 2001;50(3):312-20. PMID 11558787
102: Ryan MM, Sy C, Rudge S, et al. Dietary L-tyrosine supplementation in nemaline myopathy. J Child Neurol 2008;23(6):609-13. PMID 18079309
103: Sambuughin N, Yau KS, Olivé M, et al. Dominant mutations in KBTBD13, a member of the BTB/Kelch family, cause nemaline myopathy with cores. Am J Hum Genet 2010;87(6)842-7. PMID 21109227
104: Sanoudou D, Haslett JN, Kho AT, et al. Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle. Proc Natl Acad Sci U S A 2003;100(8):4666-71. PMID 12677001
105: Sarnat HB. Vimentin and desmin in maturing skeletal muscle and developmental myopathies. Neurology 1992;42:1616-24. PMID 1641160
106: Sasaki M, Yoneyama H, Nonaka I. Respiratory muscle involvement in nemaline myopathy. Pediatr Neurol 1990;6(6):425-7. PMID 1963532
107: Scacheri PC, Hoffman EP, Fratkin JD, et al. A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy. Neurology 2000;55(11):1689-96. PMID 11113224
108: Scheibe F, Ostendorf L, Prüss H, et al. Daratumumab for treatment-refractory antibody-mediated diseases in neurology. Eur J Neurol 2022;29(6):1847-54. PMID 35098616
109: Schroder R, Reimann J, Salmikangas P, et al. Beyond LGMD1A: myotilin is a component of central core lesions and nemaline rods. Neuromuscul Disord 2003;13(6):451-5. PMID 12899871
110: Seitz RJ, Toyka KV, Wechsler W. Adult-onset mixed myopathy with nemaline rods, minicores, and central cores: a muscle disorder mimicking polymyositis. J Neurol 1984;231:103-8. PMID 6481414
111: Sewry CA. The role of immunocytochemistry in congenital myopathies. Neuromuscul Disord 1998;8(6):394-400. PMID 9713857
112: Sewry CA, Dubowitz V. Case presentation at the 33rd ENMC International workshop: Nemaline myopathy, Naarden, the Netherlands, 1996.
113: Shafi NB, Parker JC Jr, Atkinson JB, Parker JR. Novel presentation of central core disease with nemaline bodies (rods) in the setting of diploid/triploid mosaicism. Ann Clin Lab Sci 2007;37(2):177-81. PMID 17522375
114: Shafiq SA, Dubowitz V, Peterson H de C, Milhorat AT. Nemaline myopathy: report of a fatal case, with histochemical and electron microscopic studies. Brain 1967;90(4):817-28. PMID 4169453
115: Shahar E, Tervo RC, Murphy EG. Heterogeneity of nemaline myopathy. A follow-up study of 13 cases. Pediatr Neurosci 1988;14(5):236-40. PMID 3267818
116: Shimomura C, Nonaka I. Nemaline myopathy: comparative muscle histochemistry in the severe neonatal, moderate congenital, and adult-onset forms. Pediatr Neurol 1989;5(1):25-31. PMID 2712935
117: Shy GM, Engel WK, Somers JE, Wanko T. Nemaline myopathy. A new congenital myopathy. Brain 1963;86:793-810. PMID 14090530
118: Simpson DM, Bender AN. Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol 1988;24:79-84. PMID 2843080
119: Smith PE, Edwards RH, Calverley PM. Mechanisms of sleep disordered breathing in chronic neuromuscular disease: implications for management. Q J Med 1991;81(296):961-73. PMID 1808641
120: Splawski I, Timothy KW, Decher N, et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A 2005;102(23):8089-96. PMID 15863612
121: Strickland CD, Midgett C, Tilton A, et al. Clinical and pathological variability of congenital myopathies caused by mutations in skeletal muscle alpha-actin. Am J Hum Genet 2000;67(suppl 2):379.
122: Stromer MH, Tabatabai LB, Robson RM, Goll DE, Zeece MG. Nemaline myopathy, an integrated study: selective extraction. Exp Neurol 1976;50:402-21. PMID 174926
123: Stuhlfauth I, Jennekens FG, Willemse J, Jockusch BM. Congenital nemaline myopathy. II. Quantitative changes in alpha-actinin and myosin in skeletal muscle. Muscle Nerve 1983;6:69-74. PMID 6302503
124: Tajshargi H, Ohlsson M, Lindberg C, Oldfors A. Congenital myopathy with nemaline rods and cap structures caused by a mutation in the beta-tropomyosin gene (TPM2). Arch Neurol 2007;64(9):1334-8. PMID 17846275
125: Tamura Y, Matsui K, Yaguchi H, Hashimoto M, Inoue K. Nemaline rods in chorea-acanthocytosis. Muscle Nerve 2005;31(4):516-9. PMID 15660376
126: Tanaka K, Toyoshima I, Fukuhara N, Miyatake T. An electrophoretic study of the muscle proteins in nemaline myopathy: a new method using type-defined freeze-dried sections. No To Shinkei 1984;36(1):57-63. PMID 6732976
127: Tonino P, Pappas CT, Hudson BD, Labeit S, Gregorio CC, Granzier H. Reduced myofibrillar connectivity and increased Z-disk width in nebulin-deficient skeletal muscle. J Cell Sci 2010;123(Pt 3):384-91. PMID 20053633
128: Vandamme D, Lambert E, Waterschoot D, et al. alpha-Skeletal muscle actin nemaline myopathy mutants cause cell death in cultured muscle cells. Biochim Biophys Acta 2009;1793(7):1259-71. PMID 19393268
129: Vandebrouck A, Domazetovska A, Mokbel N, Cooper ST, Ilkovski B, North KN. In vitro analysis of rod composition and actin dynamics in inherited myopathies. J Neuropathol Exp Neurol 2010;69(5):429-41. PMID 20418783
130: Voermans NC, Minnema M, Lammens M, et al. Sporadic late-onset nemaline myopathy effectively treated by melphalan and stem cell transplant. Neurology 2008;71(7):532-4. PMID 18565829
131: Vogel C, Manwani P, Cornford ME, Heinze ER. Nemaline myopathy in newly diagnosed systemic lupus erythematosus and Sjögren's overlap syndrome complicated by macrophage activation syndrome. BMC Rheumatol 2022;6(1):21. PMID 35287748
132: Volpe P, Damiani E, Margreth A, Pellegrini G, Scarlato G. Fast to slow change of myosin in nemaline myopathy: electrophoretic and immunologic evidence. Neurology 1982;32:37-41. PMID 7198731
133: Wallefeld W, Krause S, Nowak KJ, et al. Severe nemaline myopathy caused by mutations of the stop codon of the skeletal muscle alpha actin gene (ACTA1). Neuromuscul Disord 2006;16(9-10):541-7. PMID 16945536
134: Wallgren-Pettersson C. Congenital nemaline myopathy. A clinical follow-up of twelve patients. J Neurol Sci 1989;89:1-14. PMID 2926439
135: Wallgren-Pettersson C, Hiilesmaa VK, Paatero H. Pregnancy and delivery in congenital nemaline myopathy. Acta Obstet Gynecol Scand 1995;74(8):659-61. PMID 7660780
136: Wallgren-Pettersson C, Laing NG. 138th ENMC Workshop: Nemaline Myopathy, 20-22 May 2005, Naarden, The Netherlands. Neuromuscul Disord 2006;16(1):54-60. PMID 16368239
137: Wallgren-Pettersson C, Lehtokari VL, Kalimo H, et al. Distal myopathy caused by homozygous missense mutations in the nebulin gene. Brain 2007;130(Pt 6):1465-76. PMID 17525139
138: Wallgren-Pettersson C, Pelin K, Nowak KJ, et al. Genotype-phenotype correlations in nemaline myopathy caused by mutations in the genes for nebulin and skeletal muscle alpha-actin. Neuromuscul Disord 2004;14(8-9):461-70. PMID 15336686
139: Wallgren-Pettersson C, Rapola J, Donner M. Pathology of congenital nemaline myopathy. A follow-up study. J Neurol Sci 1988;83:243-57. PMID 3356991
140: Wallgren-Pettersson C, Sainio K, Salmi T. Electromyography in congenital nemaline myopathy. Muscle Nerve 1989;12:587-93. PMID 2674705
141: Wang CH, Dowling JJ, North K, et al. Consensus statement on standard of care for congenital myopathies. J Child Neurol 2012;27(3): 363-82. PMID 22431881
142: Wang X, Huang QQ, Breckenridge MT, et al. Cellular fate of truncated slow skeletal muscle troponin T produced by Glu180 nonsense mutation in amish nemaline myopathy. J Biol Chem 2005;280(8):13241-9. PMID 15665378
143: Witt CC, Burkart C, Labeit D, et al. Nebulin regulates thin filament length, contractility, and Z-disk structure in vivo. EMBO J 2006;25(16):3843-55. PMID 16902413
144: Yuen M, Sandaradura SA, Dowling JJ, et al. Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy. J Clin Invest 2014;124(11):4693-708. PMID 25250574

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Authors

Yelena Wilson DO

Dr. Wilson of Akron Children's Hospital has no relevant financial relationships to disclose.
See Profile
Jennifer Baccon MD PhD MHCM

Dr. Baccon of Akron Children's Hospital and Northeast Ohio Medical University has no relevant financial relationships to disclose.
See Profile

Editor

Harvey B Sarnat MS MD FRCPC

Dr. Sarnat of the University of Calgary has no relevant financial relationships to disclose.
See Profile

Former Authors

Monique Ryan MD and Susan T Iannaccone MD

Patient Profile

Age range of presentation: 0 month to 65+ years
Sex preponderance: male=female
Heredity: heredity may be a factor

heredity typical

autosomal dominant

autosomal recessive
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-9: Myopathy, nemaline: 359.0
ICD-10: Myopathy, nemaline: G71.2
OMIM: Nemaline myopathy 3: #161800

Nemaline myopathy 2: #256030

Amish nemaline myopathy: #605355

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Nemaline myopathy

Differential Diagnosis

Prader-Willi syndrome
myotubular myopathy
Pompe disease
congenital myasthenic syndromes
transient neonatal myasthenia gravis
- spinal muscular atrophy
- congenital hypomyelinating neuropathies

Also Relevant

Congenital muscle fiber-type disproportion
Neuromuscular pathology: overview

Clinical Categories

Patient Handouts

Congenital myopathy

Web References

Guidelines

AAN: Neuromuscular guidelines

	• Human immunodeficiency virus (HIV) in sporadic late-onset nemaline myopathy
	• Monoclonal gammopathy of undetermined significance (MGUS) in sporadic late-onset nemaline myopathy autoimmune disease in sporadic late-onset nemaline myopathy

Nemaline myopathy

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Authors

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

X-linked hydrocephalus (L1 syndrome)

Neurogenetics and genetic and genomic testing

Cerebro-oculo-facio-skeletal syndrome

Asymptomatic hyperCKemia

Limb-girdle muscular dystrophies

Chronic progressive external ophthalmoplegia

Schizencephaly

Fetal anticonvulsant syndrome

This is an article preview.
Start a Free Account
to access the full version.